Musculoskeletal Disorders Market Scenario | DelveInsight
How Robots Are Introducing A New Dimension To Healthcare Service Delivery
pharma-news-and-updates-for-Ascendis-MicroTransponder-BioMarin-Zimmer-Biomet-Canary-Medical
Ascendis’s SKYTROFA; MicroTrans...

FDA's Green Flag to Ascendis's Once-Weekly SKYTROFA for Treatment of Pediatric Growth Hormone Deficiency Fo...

leading-companies-in-the-musculoskeletal-disorders-market
Analyzing the Implication of Musculos...

As per the WHO, “worldwide approximately 1.71 billion people have a musculoskeletal condition”. Musculoskel...

key-companies-in-the-bone-cancer-treatment-market-
Diagnosis Delays, Ineffective Treatme...

Over the past few decades, the incidence and prevalence of Cancer have grown significantly which has result...

recent-pharma-happenings-for-pfizer-abcellera-sarepta-eli-lilly
Pfizer hit by DMD delay & halts BCMA trials; Sarepta’s drug shows promise in Phase II;...

Pfizer suffers a DMD delay and halts BCMA trials amid safety woes Pfizer has paused after seeing three cases of peripheral neuropathy in an early-stage study, enrollment in a critical ana...


osteoporosis-symptoms-risk-factors-diagnosis-and-treatment-options
How Is Osteoporosis Impacting The Quality Of Life?

Osteoporosis is a significant health burden worldwide and associated with pain and decreased physical, social, and mental well-being. The affected person experiences prolonged immobilisation and l...


recent-pharma-news-update
MedTech Industry Roars Back as FDA Approvals Soar

Zimmer Biomet Receives FDA Approval for its Rosa SystemOn 20 April 2021, Zimmer Biomet received FDA 510(k) clearance for its Rosa Partial Knee system for robotically-assisted partial knee repl...


chimeric-antigen-receptor-therapies-in-blood-cancers
A New Addition to Existing Chimeric Antigen Receptor Therapies –Potential for a Game Changer in B...

Chimeric Antigen Receptor (CAR) Therapies have changed the treatment paradigm of hematological malignancies to a vast extent. These personalized therapies have not only evolved as a game-changer i...


Latest-biotech-pharma-news-updates-for-ajinomot-pfizer-ikena-lilly-bright-peak
Bright Peak, Ajinomoto to Create Novel Immunocytokines; FDA’s Rejection to Lilly/Pfizer’s T...

Bright Peak Therapeutics, Ajinomoto Collaborates to Create Novel ImmunocytokinesBright Peak Therapeutics has announced a research and licensing collaboration with Ajinomoto to incorporate AJIC...


Chronic Pain Market Landscape | Chronic Pain Pipeline | Osteoarthritis
Emerging Therapies in the Chronic Pain Pipeline Transforming the Chronic Pain Market Landscape

More than 100 million people are living with one or the other form of Chronic Pain in the USA, says the Institute of Medicine. The available treatments to tackle cancer, as well as non-cancer pain...


Chronic Obstructive Pulmonary Disease Market
Chronic Obstructive Pulmo...

According to WHO, Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death g.....

Myelodysplastic Syndrome (MDS) Market Analysis
Myelodysplastic Syndrome ...

Well, MDS being one of the rare blood cancers, has been into the limelight of researchers since a de.....

Prostate Cancer Market
Prostate Cancer...

Prostate Cancer is the second most common malignancy in men worldwide, after lung cancer. Most Prost.....

Editor's Pick
Healthcare Data Breach: What it Means for Companies and the Consumer?

Data and analytics today are playing a major role in the organization’s growth. Stakeho...

Onychomycosis Therapy Market Set to Balloon Up as Emerging Novel Therapies Co...

Onychomycosis is the most commonly prevalent nail infection in adults. It is a fungal i...

Angelman syndrome Pipeline: Unmet needs call for a robust pipeline

The necessity of a robust Angelman syndrome pipeline is indispensable at the current mo...

The New Buzz of Transcranial Stimulation Devices in the Neurological Disorder...

Neurological disorders are one of the major causes of death and disability across the g...

Leading Autoimmune Diseases to Undergo Robust Improvement in Treatment by Maj...

As per the American Autoimmune Related Diseases Association (AARDA), nearly 50 million ...